key: cord-0843020-dsg1bqli
authors: Paolino, Giovanni; Canti, Valentina; Raffaele Mercuri, Santo; Rovere Querini, Patrizia; Candiani, Massimo; Pasi, Federica
title: Diffuse cutaneous manifestation in a new mother with COVID‐19 (SARS‐Cov‐2)
date: 2020-05-02
journal: Int J Dermatol
DOI: 10.1111/ijd.14919
sha: d1b3822f36c739fbd34f63ddc02f845e85e921b2
doc_id: 843020
cord_uid: dsg1bqli

nan

with an underlying bilateral interstitial pneumonia is a complication of this infection, causing a respiratory failure that in some cases requires invasive or noninvasive mechanical ventilation.

In addition, a large number of recent cases characterized by viral-related thrombophilic vasculitis are increasingly observed.

A mild leukopenia and an elevation of lactate dehydrogenase (LDH) can be present in COVID-19 patients. 1 Finally, neurological symptoms (such as ageusia and anosmia) also highlight a neurological tropism of SARS-Cov-2. In most cases, the disease passes asymptomatically or with only mild symptoms without requiring any hospitalization with only a period of quarantine at home. 4 As with all other viral diseases, the skin can also be affected in COVID-19 patients. A 37-year-old Caucasian woman, in her 7th postpartum day, developed fever (up to 39°C), dry cough, myalgia, and arthralgia; her husband developed the same symptoms. Her personal medical history was negative for cutaneous and internal diseases, she denied any allergies, the childbirth had no complications, and routine laboratory investigations did not show abnormalities. Five days before the onset of these symptoms, the patient had direct contact with an asymptomatic COVID-19 patient, confirmed with a nasopharyngeal and oropharyngeal swab. There were no signs of dyspnea, and the vital signs (including saturation) were all in normal range. A diagnosis of COVID-19 was made. The patient was obligated to quarantine at home and was advised to come to the hospital only in the event of clinical worsening. A symptomatic treatment with only acetaminophen was prescribed.

Breastfeeding has not been suspended. Currently, there are only two articles that described a total of 19 cases of cutaneous manifestations in COVID-19 patients, mainly characterized by erythematous rash, widespread urticaria, chickenpox-like vesicles, with a predilection for the trunk 1 and one case presenting with a skin rash with petechiae resembling dengue. 5 However, in both articles, the authors did not report any picture of the described cutaneous lesions. [1] [2] [3] [4] [5] While there are two recent reports that highlight the presence of acro-ischemia due to an existence of hypercoagulation status associated with COVID-19, this was not observed in our patient. 5, 6 Our case shows a cutaneous manifestation in a new mother with COVID-19 characterized by the simultaneous pres- 

Cutaneous manifestations in COVID-19: a first perspective

Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modeling study

Estimates of the severity of coronavirus disease 2019: a model-based analysis

COVID-19 can present with a rash and be mistaken for Dengue

Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia

Acute acro-ischemia in the child at the time of COVID19

Epidemiological Characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics 2020. pii: e20200702

Funding source: None. doi: 10.1111/ijd.14919